Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis

General Hospital Psychiatry

Volumn 32, Issue 5, 2010, Pages 503-508

  Seok, Jeong Ho ^a   Kim, Lee Su ^b   Hong, Narei ^b   Hong, Hyun Ju ^b   Kim, Su Jin ^b   Kang, Hee Joon ^c   Jon, Duk In ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Hallym University Sacred Heart Hospital   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Breast cancer; Depressive symptom; HPA axis dysfunction; Mental adjustment

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; NEUROENDOCRINE SYSTEM; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; SELF CONCEPT; SOCIAL PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANXIETY DISORDERS; AROUSAL; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; PERSONALITY INVENTORY; PITUITARY-ADRENAL SYSTEM; PSYCHOMETRICS; PSYCHOTHERAPY; SELF CONCEPT;

EID: 77956875155     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2010.06.001     Document Type: Article

References (37)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66.
2. Ministry H.W. Cancer incidence in Korea 1999-2001 2005, Ministry of Health and Welfare, Republic of Korea.
3. Kraus P.L. Body image, decision making, and breast cancer treatment. Cancer Nurs 1999, 22(6):421-427. [quiz 8-9].
4. Massie M.J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004, (32):57-71.
5. Hall A., A'Hern R., Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?. Eur J Cancer 1999, 35(1):79-85.
6. Holland J.C., Romano S.J., Heiligenstein J.H., Tepner R.G., Wilson M.G. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998, 7(4):291-300.
7. van Heeringen K., Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry 1996, 169(4):440-443.
8. Daniels J., Kissane D.W. Psychosocial interventions for cancer patients. Curr Opin Oncol 2008, 20(4):367-371.
9. Wong-Kim E.C., Bloom J.R. Depression experienced by young women newly diagnosed with breast cancer. Psychooncology 2005, 14(7):564-573.
10. Kissane D.W., Clarke D.M., Ikin J., Bloch S., Smith G.C., Vitetta L., et al. Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med J Aust 1998, 169(4):192-196.
11. Bennett K.K., Compas B.E., Beckjord E., Glinder J.G. Self-blame and distress among women with newly diagnosed breast cancer. J Behav Med 2005, 28(4):313-323.
12. Meyer S.E., Chrousos G.P., Gold P.W. Major depression and the stress system: a life span perspective. Dev Psychopathol 2001, 13(3):565-580.
13. Musselman D.L., Miller A.H., Porter M.R., Manatunga A., Gao F., Penna S., et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001, 158(8):1252-1257.
14. Ribeiro S.C., Tandon R., Grunhaus L., Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 1993, 150(11):1618-1629.
15. Giese-Davis J., Wilhelm F.H., Conrad A., Abercrombie H.C., Sephton S., Yutsis M., et al. Depression and stress reactivity in metastatic breast cancer. Psychosom Med 2006, 68(5):675-683.
16. Rhee M.K., Lee Y.H., Park S.H., Sohn C.H., Chung Y.C., Hong S.K., et al. A standardization study of Beck Depression Inventory I - Korean Version (K-BDI): reliability and factor analysis. Kor J Psychopathol 1995, 4:77-95.
17. Ahn Y.M., Lee K.Y., Yi J.S., Kang M.H., Kim D.H., Kim J.R., et al. A validation study of the Korean-version of the Montgomery-Asberg Depression Rating Scale. J Korean Neuropsychiatr Assoc 2005, 44(4):466-476.
18. Kim JH. Relations of perceived stress, cognitive set, and coping behaviors to depression: a focus on freshmen's stress experience [dissertation]. Seoul: Seoul National University, 1987.
19. Kim Y.C. Likableness and imagery ratings of 400 personality-describing adjectives. Keimyung University Social Science Collection of Treaties. (Korean language) 1984, 2:17-32.
20. Kim K.I., Kim D.H., Choi J.H., Park Y.C., Lee J.H., Ahn M.J., et al. A preliminary study on development of Korean version of Mental Adjustment to Cancer Scale. J Korean Assoc Soc Psychiatry 2003, 8:133-140.
21. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 1981, 38(1):15-22.
22. Weisman A.D., Worden J.W. The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med 1976, 7(1):1-15.
23. Heim E., Valach L., Schaffner L. Coping and psychosocial adaptation: longitudinal effects over time and stages in breast cancer. Psychosom Med 1997, 59(4):408-418.
24. Reardon K.K., Buck R. Emotion, reason, and communication in coping with cancer. Health Commun 1989, 1(1):41-54.
25. Watson M., Greer S., Rowden L., Gorman C., Robertson B., Bliss J.M., et al. Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients. Psychol Med 1991, 21(1):51-57.
26. Iwamitsu Y., Shimoda K., Abe H., Tani T., Okawa M., Buck R. Anxiety, emotional suppression, and psychological distress before and after breast cancer diagnosis. Psychosomatics 2005, 46(1):19-24.
27. McClelland D.C., Alexander C., Marks E. The need for power, stress, immune function, and illness among male prisoners. J Abnorm Psychol 1982, 91(1):61-70.
28. Musselman D.L., DiBattista C., Nathan K.I., Kilts C.D., Schatzberg A.F., Nemeroff C.B. Biology of mood disorders. American Psychiatric Press textbook of psychopharmacology 1998, APA Press, Washington, DC, p. 549-88. 2nd ed. A.F. Schatzberg, C.B. Nemeroff (Eds.).
29. Nemeroff C.B. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology 1992, 6(2):69-75.
30. Soygur H., Palaoglu O., Akarsu E.S., Cankurtaran E.S., Ozalp E., Turhan L., et al. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(6):1242-1247.
31. Leonard B.E. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 2005, 20(Suppl 3):S302-S306.
32. Lang R.A., Cuthbertson R.A., Dunn A.R. TNF alpha, IL-1 alpha and bFGF are implicated in the complex disease of GM-CSF transgenic mice. Growth Factors 1992, 6(2):131-138.
33. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann N Y Acad Sci 1993, 697:53-60.
34. Cowen PJ. Not fade away: the HPA axis and depression. Psychol Med 40(1):1-4.
35. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002, 7(3):254-275.
36. De Bellis M.D., Gold P.W., Geracioti T.D., Listwak S.J., Kling M.A. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry 1993, 150(4):656-657.
37. Tennen H., Herzberger S. Depression, self-esteem, and the absence of self-protective attributional biases. J Pers Soc Psychol 1987, 52(1):72-80.